Results for tag: "Juluca"

Juluca is a brand of HIV/AIDS drugs developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. Juluca is a two-drug regimen that combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor rilpivirine. It is the first two-drug regimen approved by the US Food and Drug Administration (FDA) for the treatment of HIV-1 infection in adults. Juluca is designed to reduce the number of pills taken daily and to reduce the risk of drug resistance. The Juluca market is composed of a variety of companies that produce and distribute HIV/AIDS drugs. These companies include Gilead Sciences, Merck & Co., Bristol-Myers Squibb, AbbVie, and Janssen Pharmaceuticals. Other companies in the market include ViiV Healthcare, Mylan, and Teva Pharmaceuticals. These companies are involved in the research, development, and distribution of HIV/AIDS drugs, as well as providing support services to those living with HIV/AIDS. Show Less Read more